Monday June 26th 2017

Archive for May, 2015

Learning to fly with broken wings – forcing a reappraisal of time and space

Learning to fly with broken wings – forcing a reappraisal of time and space

ConclusionLiving with a chronic disease such as MS means learning to fly with broken wings, which involves subordination to the body leading to a higher level of integration in the process of becoming towards health and well‐being. (Source: Scandinavian Journal of Caring [Read More]

Change in vital signs after fingolimod initiation in patients with multiple sclerosis: the possible need for 24‐h monitoring

Change in vital signs after fingolimod initiation in patients with multiple sclerosis: the possible need for 24‐h monitoring

(Source: British Journal of Clinical Pharmacology)MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too. [Read More]

Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

This article is protected by copyright. All rights reserved. PMID: 26032048 (Source: Immunology) [Read More]

 Page 1 of 122  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]